A complete compilation of matrix metalloproteinase expression in human malignant gliomas

被引：95

作者：

Hagemann, Carsten ^{[1
]}

Anacker, Jelena ^{[2
]}

Ernestus, Ralf-Ingo ^{[1
]}

Vince, Giles H. ^{[1
]}

机构：

[1] Univ Wurzburg, Dept Neurosurg, Tumorbiol Lab, Josef Schneider Str 11, D-97080 Wurzburg, Germany

[2] Univ Wurzburg, Dept Obstet & Gynaecol, D-97080 Wurzburg, Germany

来源：

WORLD JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 3卷 / 05期

关键词：

Astrocytic tumor; Expression pattern; Glioblastoma cell-lines; Glioblastoma multiforme; Matrix metalloproteinase;

D O I：

10.5306/wjco.v3.i5.67

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Glioblastomas are characterized by an aggressive local growth pattern, a marked degree of invasiveness and poor prognosis. Tumor invasiveness is facilitated by the increased activity of proteolytic enzymes which are involved in destruction of the extracellular matrix of the surrounding healthy brain tissue. Elevated levels of matrix metalloproteinases (MMPs) were found in glioblastoma (GBM) cell-lines, as well as in GBM biopsies as compared with low-grade astrocytoma (LGA) and normal brain samples, indicating a role in malignant progression. A careful review of the available literature revealed that both the expression and role of several of the 23 human MMP proteins is controversely discussed and for some there are no data available at all. We therefore screened a panel of 15 LGA and 15 GBM biopsy samples for those MMPs for which there is either no, very limited or even contradictory data available. Hence, this is the first complete compilation of the expression pattern of all 23 human MMPs in astrocytic tumors. This study will support a better understanding of the specific expression patterns and interaction of proteolytic enzymes in malignant human glioma and may provide additional starting points for targeted patient therapy. (C) 2012 Baishideng. All rights reserved.

引用

页码：67 / 79

页数：13

共 135 条

[1] EXPRESSION OF 72-KDA TYPE-IV COLLAGENASE AND INVASION ACTIVITY OF HUMAN GLIOMA-CELLS [J].

ABE, T ;

MORI, T ;

KOHNO, K ;

SEIKI, M ;

HAYAKAWA, T ;

WELGUS, HG ;

HORI, S ;

KUWANO, M .

CLINICAL & EXPERIMENTAL METASTASIS, 1994, 12 (04) :296-304

[2] Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain [J].

Agarwal, Sagar ;

Sane, Ramola ;

Oberoi, Rajneet ;

Ohlfest, John R. ;

Elmquist, William F. .

EXPERT REVIEWS IN MOLECULAR MEDICINE, 2011, 13 :e17

[3] A MT1-MMP/NF-κB signaling axis as a checkpoint controller of COX-2 expression in CD133(+) U87 glioblastoma cells [J].

Annabi, Borhane ;

Laflamme, Carl ;

Sina, Asmaa ;

Lachambre, Marie-Paule ;

Beliveau, Richard .

JOURNAL OF NEUROINFLAMMATION, 2009, 6

[4] Cell-mediated drug delivery [J].

Batrakova, Elena V. ;

Gendelman, Howard E. ;

Kabanov, Alexander V. .

EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (04) :415-433

[5] Primary brain tumours in adults [J].

Behin, A ;

Hoang-Xuan, K ;

Carpentier, AF ;

Delattre, JY .

LANCET, 2003, 361 (9354) :323-331

[6] Novel Drug Delivery Strategies in Neuro-Oncology [J].

Bidros, Dani S. ;

Vogelbaum, Michael A. .

NEUROTHERAPEUTICS, 2009, 6 (03) :539-546

[7] Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas [J].

Biernat, W ;

Tohma, Y ;

Yonekawa, Y ;

Kleihues, P ;

Ohgaki, H .

ACTA NEUROPATHOLOGICA, 1997, 94 (04) :303-309

[8] Putting tumours in context [J].

Bissell, MJ ;

Radisky, D .

NATURE REVIEWS CANCER, 2001, 1 (01) :46-54

[9] Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases [J].

Borden, P ;

Heller, RA .

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 1997, 7 (1-2) :159-178

[10] Tissue inhibitors of metalloproteinases: evolution, structure and function [J].

Brew, K ;

Dinakarpandian, D ;

Nagase, H .

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283

← 1 2 3 4 5 6 7 8 9 10 →